1. Home
  2. Labeler Index
  3. Takeda Pharmaceuticals America, Inc.
  4. 59417-120
  5. NDC Package Code: 59417-120-01 Vyvanse

NDC Package 59417-120-01 Vyvanse

Lisdexamfetamine Dimesylate Tablet, Chewable Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
59417-120-01
Package Description:
100 TABLET, CHEWABLE in 1 BOTTLE
Product Code:
59417-120
Proprietary Name:
Vyvanse
Non-Proprietary Name:
Lisdexamfetamine Dimesylate
Substance Name:
Lisdexamfetamine Dimesylate
Usage Information:
Lisdexamfetamine is used to treat attention deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, stay focused, and stop fidgeting. Lisdexamfetamine may also be used to treat binge eating disorder (BED). It may help to reduce the number of binge eating days. This medication is a stimulant. It is thought to work by restoring the balance of certain natural chemicals (neurotransmitters) in the brain. This medication is not recommended for use for weight loss due to the risk of serious side effects.
11-Digit NDC Billing Format:
59417012001
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
100 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1593856 - lisdexamfetamine dimesylate 10 MG Oral Capsule
  • RxCUI: 1593858 - Vyvanse 10 MG Oral Capsule
  • RxCUI: 1593858 - lisdexamfetamine dimesylate 10 MG Oral Capsule [Vyvanse]
  • RxCUI: 1871456 - lisdexamfetamine dimesylate 40 MG Chewable Tablet
  • RxCUI: 1871459 - Vyvanse 40 MG Chewable Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Takeda Pharmaceuticals America, Inc.
    Dosage Form:
    Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • LISDEXAMFETAMINE DIMESYLATE 60 mg/1
    • Pharmacologic Class(es):
  • Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
  • Central Nervous System Stimulation - [PE] (Physiologic Effect)
    • DEA Schedule:
    Schedule II (CII) Substances
    Sample Package:
    No
    FDA Application Number:
    NDA208510
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    01-28-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 59417-120-01?

    The NDC Packaged Code 59417-120-01 is assigned to a package of 100 tablet, chewable in 1 bottle of Vyvanse, a human prescription drug labeled by Takeda Pharmaceuticals America, Inc.. The product's dosage form is tablet, chewable and is administered via oral form.

    Is NDC 59417-120 included in the NDC Directory?

    Yes, Vyvanse with product code 59417-120 is active and included in the NDC Directory. The product was first marketed by Takeda Pharmaceuticals America, Inc. on January 28, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 59417-120-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 100.

    What is the 11-digit format for NDC 59417-120-01?

    The 11-digit format is 59417012001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-259417-120-015-4-259417-0120-01